Natera at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Natera brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 445. Its session covers advances in molecular residual disease testing and the expanding role of digital pathology and artificial intelligence. The company runs cell-free DNA testing, including a custom circulating tumor DNA test for residual disease and treatment monitoring.

OrganizationAMP 2026 Attendance
Natera
San Carlos, CA
natera.com
Diagnostics
Cell-free DNA testing company; Signatera is a custom ctDNA test for molecular residual disease assessment and treatment monitoring.
Booth
Exhibiting at Booth 445
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
4:00pm–4:50pm
Title: Advancements in MRD Testing: The Expanding Role of Digital Pathology and AI
Digital pathology and machine learning applied to specimen assessment and interpretation in residual disease testing.
Skagit 5, Lower Level, Arch at 800 Pike

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Natera

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction